Protection against the Omicron Variant from Previous SARS-CoV-2 Infection

Cited by (428)

Items 201–300 of 428

1. An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity
   Emma Chang-Rabley, Menno C. van Zelm, Emily Ricotta, Emily S.J. Edwards · 2024 · Vaccines
2. Immediate reinfection with Omicron variant after clearance of a previous SARS-CoV-2 infection
   Antonella Mencacci, Alessio Gili, Barbara Camilloni, Giulia Bicchieraro, Roberta Spaccapelo, Carla Bietta, Fabrizio Stracci · 2022 · Journal of Infection and Public Health
3. Antibody Responses to the SARS-CoV-2 Ancestral Strain and Omicron Variants in Moderna mRNA-1273 Vaccinated Active-Duty US Navy Sailors and Marines
   Peifang Sun, Corey A. Balinsky, Le Jiang, Vihasi Jani, Tran Khanh Long, Ying Cheng, Mary Ann Serote, Andrew B Smith, Burnetta F Fears, Stephanie K. Gatrell et al. · 2023 · The Journal of Infectious Diseases
4. Maintaining immunological memory to the SARS-CoV-2 virus during COVID-19 pandemic
   А. П. Топтыгина, Zulfiia E. Afridonova, Закиров Рустам Шакирович, Elena L. Semikina · 2023 · Russian Journal of Infection and Immunity
5. Modelling the impact of hybrid immunity on future COVID-19 epidemic waves
   Thao P. Le, Isobel R. Abell, Eamon J Conway, Patricia T. Campbell, Alexandra B. Hogan, Michael Lydeamore, Jodie McVernon, Ivo Müeller, Camelia R. Walker, Christopher M. Baker · 2024 · BMC Infectious Diseases
6. Enhancing COVID-19 Vaccination Awareness and Uptake in the Post-PHEIC Era: A Narrative Review of Physician-Level and System-Level Strategies
   Kay Choong See · 2024 · Vaccines
7. TRACE‐Omicron: Policy Counterfactuals to Inform Mitigation of COVID‐19 Spread in the United States
   David O’Gara, Samuel F. Rosenblatt, Laurent Hébert‐Dufresne, Rob Purcell, Matt Kasman, Ross A. Hammond · 2023 · Advanced Theory and Simulations
8. Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
   Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Yusuke Oshiro, Natsumi Inamura, Tetsuya Mizoue, Maki Konishi, Junko S. Takeuchi, Kumi Horii, Mitsuru Ozeki et al. · 2023 · BMC Infectious Diseases
9. Humoral and cellular immunity against diverse SARS-CoV-2 variants
   Changxu Chen, Xin Wang, Zeli Zhang · 2023 · Journal of genetics and genomics/Journal of Genetics and Genomics
10. Regional Differences in Uptake of Vaccination against COVID-19 and Influenza in Germany: Results from the DigiHero Cohort
    Bianca Klee, Sophie Diexer, Myka Harun Sarajan, Nadine Glaser, Mascha Binder, Thomas Frese, Matthias Girndt, Daniel Sedding, Jessica I. Hoell, Irene Moor et al. · 2023 · Vaccines
11. Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease
    Jingyi Yan, Chandrashekar Bangalore Revanna, Negin Nikouyan, Sofia Appelberg, Daniela Nacimento Silva, Haidong Yao, Anna Pasetto, Friedemann Weber, Sofie Weber, Olivia J. Larsson et al. · 2024 · Molecular Therapy
12. Neutralisation resistance of SARS-CoV-2 spike-variants is primarily mediated by synergistic receptor binding domain substitutions
    Long V. Pham, Alexander P. Underwood, Alekxander Binderup, Ulrik Fahnøe, Carlota Fernandez-Antunez, Blanca Lopez Mendez, Line Abildgaard Ryberg, Andrea Galli, Christina Søhoel Sølund, Nina M Weis et al. · 2024 · Emerging Microbes & Infections
13. SARS-CoV-2 transmission and impacts of unvaccinated-only screening in populations of mixed vaccination status
    Kate M. Bubar, Casey E. Middleton, Kristen K. Bjorkman, Roy Parker, Daniel B. Larremore · 2022 · Nature Communications
14. Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study
    Sarah E. Turbett, Christopher H. Tomkins-Tinch, Melis N. Anahtar, Caitlin M. Dugdale, Emily Parker Hyle, Erica Seiguer Shenoy, Bennett M. Shaw, Kenechukwu Egbuonu, Kathryn A. Bowman, Kimon C. Zachary et al. · 2022 · Clinical Infectious Diseases
15. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters
    Nozomi Shiwa-Sudo, Yusuke Sakai, Naoko Iwata‐Yoshikawa, Shinji Watanabe, Souichi Yamada, Yudai Kuroda, Tsukasa Yamamoto, Masayuki Shirakura, Seiichiro Fujisaki, Kaya Miyazaki et al. · 2023 · Journal of Virology
16. Measuring T-Cell Responses against SARS-CoV-2 Is of Utility for Disease and Vaccination Management
    Guillem Safont, Irene Latorre, Raquel Villar-Hernández, Zoran Stojanović, Alicia Marín, Cristina Pérez-Cano, Alícia Lacoma, Bárbara Molina-Moya, Alan Jhunior Solis, Fernándo Arméstar et al. · 2022 · Journal of Clinical Medicine
17. Understanding the challenges to COVID-19 vaccines and treatment options, herd immunity and probability of reinfection
    Mohammad A. I. Al-Hatamleh, Mai Abdel Haleem Abusalah, Ma’mon M. Hatmal, Walhan Alshaer, Suhana Ahmad, Manali Haniti Mohd-Zahid, Engku Nur Syafirah Engku Abd Rahman, Chan Yean Yean, Iskandar Zulkarnain Alias, Vuk Uskoković et al. · 2022 · Journal of Taibah University Medical Sciences
18. BNT162b2 antigen dose and SARS-CoV-2 omicron infection in adolescents
    Hiam S. Chemaitelly, Houssein H. Ayoub, Peter Valentine Coyle, Patrick Tang, Hadi Mohamad Yassine, Asmaa A. Al Thani, Hebah A. Al-Khatib, Mohammad R. Hasan, Zaina Al Kanaani, Einas Al‐Kuwari et al. · 2023 · The Lancet Infectious Diseases
19. Discussion about the Latest Findings on the Possible Relation between Air Particulate Matter and COVID-19
    Maria Cristina Collivignarelli, Stefano Bellazzi, Francesca Maria Caccamo, Marco Carnevale Miino · 2023 · International Journal of Environmental Research and Public Health
20. COVID-19 Infection Rates in Vaccinated and Unvaccinated Inmates: A Retrospective Cohort Study
    Luke Ko, Gary Malet, Lisa L Chang, Huu Cong Nguyen, Robert Mayes · 2023 · Cureus
21. A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children
    Frances H. Priddy, Spyros Chalkias, Brandon J. Essink, Jordan L. Whatley, Adam B. Brosz, Ivan T. Lee, Jing Feng, LaRee A. Tracy, Weiping Deng, Wen Zhou et al. · 2024 · Expert Review of Vaccines
22. Understanding risk factors of a new variant outburst through global analysis of Omicron transmissibility
    Marko Djordjević, Sofija Sekulić Marković, Igor Salom, Magdalena Djordjevic · 2022 · Environmental Research
23. Retrospective study of COVID-19 experiences in elite multinational aquatic athletes
    Vencel Juhász, Emese Csulak, Liliána Erzsébet Szabó, Zsófia Ocsovszky, Dorottya Balla, György Nagy, Alessandro Zorzi, Andy I. M. Hoepelman, Béla Péter Merkely, Hajnalka Vágó et al. · 2023 · Scientific Reports
24. A bead-based multiplex assay covering all coronaviruses pathogenic for humans for sensitive and specific surveillance of SARS-CoV-2 humoral immunity
    Daniel Stern, Tanja C. Meyer, Fridolin Treindl, Hans Werner Mages, Maren Krüger, Martin Skiba, Jan Philipp Krüger, Christian Zobel, Maximilian Schreiner, Marica Grossegesse et al. · 2023 · Scientific Reports
25. Notes from the Field: SARS-CoV-2 Omicron Variant Infection in 10 Persons Within 90 Days of Previous SARS-CoV-2 Delta Variant Infection — Four States, October 2021–January 2022
    Mellisa Roskosky, Brian F. Borah, Peter M. DeJonge, Catherine Donovan, Lynn Zanardi Blevins, Allison G. Lafferty, Julia C. Pringle, Patsy Tassler Kelso, Jonathan L. Temte, Emily Temte et al. · 2022 · MMWR Morbidity and Mortality Weekly Report
26. Proposal of a population wide genome-based testing for Covid-19
    Hans Rudolf Lehrach, Jon Curtis, Bodo M. H. Lange, Lesley Ann Ogilvie, Richard Gauss, Christoph Steininger, Erhard Scholz, Matthias Kreck · 2022 · Scientific Reports
27. A Randomized Clinical Trial of a Fractional Low Dose of BNT162b2 Booster in Adults Following AZD1222
    Rapisa Nantanee, Watsamon Jantarabenjakul, Peera Jaru-Ampornpan, Pimpayao Sodsai, Orawan Himananto, Jitthiwa Athipunjapong, Jiratchaya Sophonphan, Sira Nanthapisal, Nattiya Hirankarn, Thanyawee Puthanakit · 2022 · Vaccines
28. Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron
    Linhui Hao, Tien-Ying Hsiang, Ronit R. Dalmat, Reneé C. Ireton, Jennifer F. Morton, Caleb Stokes, Jason Netland, Malika R. Hale, Chris Thouvenel, Anna Wald et al. · 2023 · Viruses
29. Induction of High Neutralizing Activity Against Both Omicron BA.2 and Omicron BA.1 by Coronavirus Disease 2019 Messenger RNA Booster Vaccination
    Lidya Handayani Tjan, Koichi Furukawa, Yukiya Kurahashi, Silvia Sutandhio, Mitsuhiro Nishimura, Jun Arii, Yasuko Mori · 2022 · The Journal of Infectious Diseases
30. Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1–2 Clinical Trial
    Gilda Lemos, Yinet Barrese Pérez, Yahima Chacón-Quintero, Rolando Uranga Piña, Yisel Ávila Albuerne, Iglermis Figueroa García, Osaida Calderín Marín, Martha M. Gómez-Vázquez, Marjoris Piñera-Martínez, Sheila Chávez-Valdés et al. · 2024 · Vaccines
31. Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination
    Hope R. Lapointe, Francis M. Mwimanzi, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Rebecca Kalikawe, Sneha Datwani, Rachel Waterworth, Gisele Umviligihozo, Siobhan Ennis et al. · 2022 · Frontiers in Immunology
32. The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants
    Chi‐Kuei Hsu, Wan‐Hsuan Hsu, Bo-Wen Shiau, Ya‐Wen Tsai, Jheng‐Yan Wu, Tinghui Liu, Po‐Yu Huang, Min‐Hsiang Chuang, Chih-Cheng Lai · 2024 · Expert Review of Anti-infective Therapy
33. Inducing Long Lasting B Cell and T Cell Immunity Against Multiple Variants of SARS‐CoV‐2 Through Mutant Bacteriophage Qβ—Receptor Binding Domain Conjugate
    Zibin Tan, Canchai Yang, Po‐Han Lin, Sherif Ramadan, Weizhun Yang, Zahra Rashidi, Shuyao Lang, Fatemeh Shafieichaharberoud, Jia Gao, Xingling Pan et al. · 2024 · Advanced Healthcare Materials
34. Differences in Immunological Evasion of the Delta (B.1.617.2) and Omicron (B.1.1.529) SARS-CoV-2 Variants: A Retrospective Study on the Veneto Region’s Population
    Silvia Cocchio, Federico Zabeo, Giacomo Facchin, Nicolò Piva, Giovanni Venturato, Thomas Marcon, Mario Saïa, Michele Tonon, Michele Mongillo, Filippo Da Re et al. · 2022 · International Journal of Environmental Research and Public Health
35. How Different Predominant SARS-CoV-2 Variants of Concern Affected Clinical Patterns and Performances of Infected Professional Players during Two Soccer Seasons: An Observational Study from Split, Croatia
    Jasna Ninčević, Anamarija Jurčev Savičević, Šime Veršić, Toni Modrić, Ante Turić, Ante Bandalović, Boris Bećir, Marijana Mijaković, Ivana Bočina, Damir Sekulić · 2023 · International Journal of Environmental Research and Public Health
36. COVID-19 Vaccine Effectiveness Against the Omicron Variant in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease
    Nabeel H. Khan, Nadim Mahmud · 2022 · The American Journal of Gastroenterology
37. Features and significance of the recent enormous COVID‐19 epidemic in China
    Jiming Chen, Huan‐Yu Gong, Rui‐Xu Chen, Si‐Tong Liu, Ming‐Hui Sun, Guo‐Hui Li, Tingting Yang, Ji‐Wang Chen · 2023 · Journal of Medical Virology
38. Use of Hu-PBL Mice to Study Pathogenesis of Human-Restricted Viruses
    Jesús Emanuel Brunetti, Maksym Kitsera, César Muñoz‐Fontela, Estefanía Rodríguez · 2023 · Viruses
39. Kinetics of neutralising antibodies against Omicron variant in Vietnamese healthcare workers after primary immunisation with ChAdOx1-S and booster with BNT162b2
    Nguyen Van Vinh Chau, Lam Anh Nguyet, Nguyen Thanh Dung, Vo Minh Quang, Nguyen Thanh Truong, Le Mau Toan, Le Manh Hung, Dinh Nguyen Huy Man, Dao Bach Khoa, Nguyen Thanh Phong et al. · 2022 · medRxiv
40. Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study
    Xiaofeng He, Biao Zeng, Ye Wang, Yulian Pang, Meng Zhang, Ting Hu, Yuanhao Liang, Min Kang, Shixing Tang · 2023 · Frontiers in Immunology
41. Hybrid immunity from severe acute respiratory syndrome coronavirus 2 infection and vaccination in Canadian adults: A cohort study
    Patrick E. Brown, Sze Hang Fu, Leslie Newcombe, Xuyang Tang, Nico J. D. Nagelkerke, H. Chaim Birnboim, Aiyush Bansal, Karen Colwill, Geneviève Mailhot, Melanie Delgado-Brand et al. · 2024 · eLife
42. Assessing the Impact of Primary-Series Infection and Booster Vaccination on Protection against Omicron in Hong Kong: A Population-Based Observational Study
    Jialiang Jiang, Eric H. Y. Lau, Ziyi Zhou, Guosheng Yin, Yun Lin, Benjamin John Cowling, Kwok Fai Lam · 2024 · Vaccines
43. Evaluating Hospital Admission Data as Indicators of COVID-19 Severity: A National Assessment in Qatar
    Layan Sukik, Hiam S. Chemaitelly, Houssein H. Ayoub, Peter Valentine Coyle, Patrick Tang, Mohammad R. Hasan, Hadi Mohamad Yassine, Asmaa A. Al Thani, Zaina Al Kanaani, Einas Al‐Kuwari et al. · 2025 · Open Forum Infectious Diseases
44. Does pre-existing immunity determine the course of SARS-CoV-2 infection in health-care workers? Single-center experience
    Luka Laura, Monika Dalmatin-Dragišić, Katarina Martinović, Borka Tutiš, Ivana Herceg, Maja Arapović, Jurica Arapović · 2022 · Infection
45. Cold-adapted SARS-CoV-2 variants with different temperature sensitivity exhibit an attenuated phenotype and confer protective immunity
    Е. Б. Файзулоев, Anastasiia V. Gracheva, E. R. Korchevaya, Daria I. Smirnova, Roman V. Samoilikov, Andrey A. Pankratov, Galina V. Trunova, Хохлова Варвара Андреевна, Yu. I. Ammour, О. А. Petrusha et al. · 2022 · Vaccine
46. Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
    Jinghao Nicholas Ngiam, Abdurrahmaan Al-Mubaarak, Sebastian Maurer‐Stroh, Paul Anantharajah Tambyah · 2022 · Singapore Medical Journal
47. Exploratory analysis of SARS-CoV-2 omicron variant and its subvariant propagation: global predominance of BA.1*, BA.2*, BA.5*, BE.1*, and BQ.1*
    Rathinasamy Muthusami, K. Saritha · 2023 · Proceedings of the Indian National Science Academy
48. Association Between Low Anti-spike Antibody Levels After the Third Dose of SARS-CoV-2 Vaccination and Hospitalization due to Symptomatic Breakthrough Infection in Kidney Transplant Recipients
    Ahram Han, Sangil Min, Eun-Ah Jo, Hajeong Lee, Yong Chul Kim, Seung Seok Han, Hee Gyung Kang, Yo Han Ahn, Inseong Oh, Eun Young Song et al. · 2023 · Annals of Laboratory Medicine
49. Lipid and cholesterols modulate the dynamics of SARS-CoV-2 viral ion channel ORF3a and its pathogenic variants
    Madhusmita Rout, Sarbani Mishra, Sunita Panda, Budheswar Dehury, Sanghamitra Pati · 2023 · International Journal of Biological Macromolecules
50. Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS‐CoV‐2 Omicron infection
    Zheng Quan Toh, Jeremy Anderson, Nadia Mazarakis, Leanne Quah, Jill Nguyen, Rachel A. Higgins, Lien Anh Ha Do, Yan Yung Ng, Sedi Jalali, Melanie R. Neeland et al. · 2024 · Clinical & Translational Immunology
51. Mandatory vaccinations, the segregation of citizens, and the promotion of inequality in the modern democracy of Greece and other democratic countries in the era of COVID-19
    Charalampos Mavridis, Georgios Aidonidis, Marianna Evangelou, Athanasios Kalogeridis · 2022 · History & Philosophy of the Life Sciences
52. Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China
    Zhiying Yin, Quanjun Fang, Tingcui Wen, Canjie Zheng, Canya Fu, Shuangqing Wang, Junji Li, Xiaoying Gong · 2023 · Human Vaccines & Immunotherapeutics
53. Evaluation of COVID-19 vaccines in primary prevention against infections and reduction in severity of illness following the outbreak of SARS-CoV-2 omicron variant in Shanghai
    Dawei Yang, Huifen Weng, Rui Wang, You Li, Hao Zhang, Shifeng Shao, Hunan Huang, Yuanlin Song, Xiaoyan Chen, Dongni Hou et al. · 2023 · Frontiers in Medicine
54. ‘Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients’: authors' response
    Maddalena Peghin, Maria De Martino, Alvisa Palese, Elena Graziano, Miriam Isola, Carlo Tascini · 2022 · Clinical Microbiology and Infection
55. Global Estimates of COVID‐19 Morbidity and Mortality: A Cohort Study and Mathematical Model Analysis
    Houssein H. Ayoub, Hiam S. Chemaitelly, Laith Jamal Abu-Raddad · 2025 · Influenza and Other Respiratory Viruses
56. Live attenuated COVID-19 vaccines: approaches to development and prospects for clinical use
    E. R. Korchevaya, Anastasiia V. Gracheva, Ilya N. Dyakov, В. В. Зверев, Е. Б. Файзулоев · 2023 · Journal of microbiology epidemiology immunobiology
57. Long- and short-term effects of cross-immunity in epidemic dynamics
    Iker Atienza-Diez, Luís F. Seoane · 2023 · Chaos Solitons & Fractals
58. Maternal Immunizations: Past, Present, and Future
    Anne-Marie Rick, Richard H. Beigi · 2024 · Clinical Obstetrics & Gynecology
59. Improved Survival of Lymphoma Patients with COVID-19 in the Modern Treatment and Vaccination Era
    Alexandra Della Pia, Charles Zhao, Parul Jandir, Amolika Gupta, Mark Batistick, Gee Youn Kim, Yi Xia, Jaeil Ahn, Gabriella Magarelli, Brittany Lukasik et al. · 2022 · Cancers
60. COVID-19 Pandemic: End of emergency, but not end of challenge
    Rongrong Song, Jiuyang Xu, Bin Cao · 2023 · The Innovation Medicine
61. Analytical tool for COVID-19 using an SIR model equivalent to the chain reaction equation of infection
    Koichiro Maki · 2023 · Biosystems
62. COVID-19 vaccines and beyond
    Yiyuan Liu, Danying Li, Jiahuai Han · 2024 · Cellular and Molecular Immunology
63. SARS-CoV-2 Omicron Variant in Croatia—Rapid Detection of the First Case and Cross-Border Spread
    Ivana Ferenčak, Mihaela Obrovac, Ljiljana Žmak, Josipa Kuzle, Goranka Petrović, Tatjana Vilibić‐Čavlek, Dragan Jurić, Anita Jurić, Željka Hruškar, Krunoslav Capak et al. · 2022 · Pathogens
64. Time from last immunity event against infection during Omicron-dominant period in Malaysia
    Su Lan Yang, Adiratna Mat Ripen, Jen Ven Lee, Karina Koh, Chia How Yen, Avinash Kumar Chand, Nur Aisyah Binti Abdul Rahim, Varaalakshmy Gokilavanan, Nik Nur Eliza Mohamed, Raj Kumar Sevalingam et al. · 2022 · International Journal of Infectious Diseases
65. SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells
    Melinda Metzler, Rebecca George Tharyan, Kevin Klann, Katharina Grikscheit, Denisa Bojková, Jindrich Jr. Cinatl, Georg Tascher, Sandra Ciesek, Christian Münch · 2023 · Molecular & Cellular Proteomics
66. SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022
    Richard A. Teran, Alexandra Gagner, Stephanie R. Gretsch, Jeff Lauritsen, Daniel Galanto, Kelly Walblay, Peter Ruestow, Colin Korban, Massimo Pacilli, David Kern et al. · 2023 · Emerging infectious diseases
67. Extensive neutralization against SARS-CoV-2 variants elicited by Omicron-specific subunit vaccine as a heterologous booster
    Pai Peng, Chengqian Feng, Jie Hu, Changlong He, Haijun Deng, Qinghong Fan, Xiang Jin, Guofang Tang, Mengling Jiang, Fengyu Hu et al. · 2022 · iScience
68. Efficacy of COVID ‐19 vaccination in adult patients with sickle cell disease during the Omicron wave in France
    Julien Derdevet, Brigitte Ranque, Djamal Khimoud, Laure Joseph, Adrien Michon, Edouard Flamarion, Emmanuel Lafont, Anne Corbasson, J. Pouchot, Jean‐Benoît Arlet et al. · 2023 · European Journal Of Haematology
69. Eco-Friendly Transitions in Top Ten CO2 Producing Countries: A Dynamic Panel Investigation of Green Finance, Technology Transfer and Financial Development for Reducing Environmental Degradation
    Amna Shafqat, Sadia Idrees, Sarfraz Zaman, Muniba Ghaffar · 2023 · iRASD Journal of Economics
70. SARS-CoV-2 Omicron disease burden in Australia following border reopening: a modelling analysis
    George J. Milne, Julian Carrivick · 2022 · medRxiv
71. The changing demographics and severity in hospitalized patients across COVID-19 variants: A national cohort study
    Priyanka Parajuli, Lara A.C. Phipps, Roy Sabo, Rasha Alsaadawi, Amanda Robinson, Evan French, Richard K. Sterling · 2025 · Journal of Clinical and Translational Science
72. Effectiveness of mRNA Vaccine Booster against SARS-CoV-2 Infection and COVID-19 in the Adult Population during the First Three Months of the Omicron Wave in Sicily
    Giuseppe Vella, Dario Genovese, Miriam Belluzzo, Luca Mazzeo, Vincenzo Pisciotta, Emanuele Amodio · 2023 · Healthcare
73. Altered hACE2 binding affinity and S1/S2 cleavage efficiency of SARS-CoV-2 spike protein mutants affect viral cell entry
    Ke Wang, Yu Pan, Dianbing Wang, Ye Yuan, Min Li, Yuanyuan Chen, Lijun Bi, Xian‐En Zhang · 2023 · Virologica Sinica
74. Infection and Vaccine Induced Spike Antibody Responses Against SARS-CoV-2 Variants of Concern in COVID-19-Naïve Children and Adults
    Aleha Pillay, Avani Yeola, Fiona Tea, Martina Denkova, Samuel Houston, Rebecca Burrell, Vera Merheb, Fiona X. Z. Lee, Joseph A. Lopez, Lilly Moran et al. · 2023 · Journal of Clinical Immunology
75. Asthma control after recovery from mild to moderate COVID-19: from Omicron BA.2 to XBB– from a cohort in a university hospital in Hong Kong
    Wang Chun Kwok, Chung Ki Tsui, Terence Chi Chun Tam, David Chi Leung Lam, Msm Ip, Jcm Ho · 2025 · BMC Pulmonary Medicine
76. Neutralizing Antibodies against the SARS-CoV-2 Delta and Omicron BA.1 following Homologous CoronaVac Booster Vaccination
    Jianhua Li, Xiaoyan Li, Erqiang Wang, Jin-ye Yang, Jiaxuan Li, Chen Huang, Yanjun Zhang, Keda Chen · 2022 · Vaccines
77. Protection Conferred by Delta and BA.1/BA.2 Infection Against BA.4/BA.5 Infection and Hospitalization: A Retrospective Cohort Study
    Nicole Winchester, Nabin K. Manandhar Shrestha, Priscilla Kim, Larisa G. Tereshchenko, Michael B. Rothberg · 2023 · The Journal of Infectious Diseases
78. Clinical application of COVID-19 vaccine in liver transplant recipients
    F.C. Liu, Man Xie, Wei Hong Rao · 2023 · Hepatobiliary & pancreatic diseases international
79. To be remembered: B cell memory response against SARS‐CoV ‐2 and its variants in vaccinated and unvaccinated individuals
    Nafees Ahmed, Atharv Athavale, Ankita Harishchandra Tripathi, Adarsh Subramaniam, Santosh Kumar Upadhyay, Anil Kumar Pandey, Ramesh Chandra Rai, Amit Awasthi · 2023 · Scandinavian Journal of Immunology
80. Projecting the future impact of emerging SARS-CoV-2 variants under uncertainty: Modeling the initial Omicron outbreak
    Sean M. Moore, Sean Cavany, T. Alex Perkins, Guido España · 2024 · Epidemics
81. Multiple SARS-CoV-2 Reinfections: A Case Series of Thrice-Infected Individuals
    Melanie D. Swift, Caitlin M. Hainy, Priya Sampathkumar, Laura E. Breeher · 2022 · Mayo Clinic Proceedings
82. A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional
    Priyanka Pandit, Puneet Bhatt, Rima Rakeshkumar Sahay, Yash Joshi, Deepak Y. Patil, Pragya Dhruv Yadav · 2022 · Journal of Infection
83. Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates
    Alexander L. Lundberg, Ramón Lorenzo-Redondo, Judd F. Hultquist, Claudia Hawkins, Egon Anderson Ozer, Sarah B Welch, P. V. Vara Prasad, Chad J. Achenbach, Janine I White, James Francis Oehmke et al. · 2022 · JMIR Public Health and Surveillance
84. Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5–11 Years
    Gili Joseph, Elisheva Klein, Yaniv Lustig, Yael Weiss-Ottolenghi, Keren Asraf, Victoria Indenbaum, Sharon Amit, Or Kriger, Mayan Gilboa, Yuval Levy et al. · 2022 · Vaccines
85. Saliva and Plasma Antibody Levels in Children and Adolescents After Primary Infection With Omicron Variants of SARS-CoV-2 Infection in Germany
    Constanze Heinzel, Yudi Tatiana Pinilla, Ayla Binder, Peter G. Kremsner, Jana Held, Rolf Fendel, Andrea Kreidenweiss · 2023 · Archives of Pediatrics and Adolescent Medicine
86. Community incidence patterns drive the risk of SARS-CoV-2 outbreaks and alter intervention impacts in a high-risk institutional setting
    Sean M. Moore, Guido España, T. Alex Perkins, Robert M. Guido, Joaquin B. Jucaban, Tara Hall, Mark E Huhtanen, Sheila A. Peel, Kayvon Modjarrad, Shilpa Hakre et al. · 2023 · Epidemics
87. Omicron variant (B.1.1.529) challenge the integrity of blood brain barrier: Evidence from protein structural analysis
    Abdul Nasır, Abdus Samad, Sami Ullah, Arif Ali, Dong‐Qing Wei, Qian Bai · 2023 · Computers in Biology and Medicine
88. New Variants in SARS-CoV-2: What are we Learning from the Omicron Variant?
    Juan Carlos Galán, Rafael Cantón · 2022 · Archivos de Bronconeumología
89. Is it really time to ditch the mask?
    Rok Hrzic, Vasco Ricoca Peixoto, Amanda J. Mason‐Jones, Alison Katherine McCallum · 2022 · BMJ
90. Protection against reinfection with SARS-CoV-2 omicron BA.2.75 * sublineage
    Hiam S. Chemaitelly, Patrick Tang, Peter Valentine Coyle, Hadi Mohamad Yassine, Hebah A. Al-Khatib, Maria K. Smatti, Mohammad R. Hasan, Houssein H. Ayoub, Heba N. Altarawneh, Zaina Al Kanaani et al. · 2022 · medRxiv
91. Effect of Paxlovid in COVID-19 treatment during the periods of SARS-CoV-2 Omicron BA.5 and BN.1 subvariant dominance in the Republic of Korea: a retrospective cohort study
    Dong-Hwi Kim, Min‐Gyu Yoo, Na-Young Kim, So Young Choi, Minjeong Jang, Misuk An, Se‐Jin Jeong, Jungyeon Kim · 2024 · Osong Public Health and Research Perspectives
92. Prior SARS-CoV-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster
    Brianna T. Wachter, Qin Xu, Lihong Shi, Peter D. Burbelo, Kathy Myint-Hpu, Pamela L. Schwartzberg, Muhammad Tauseef Rehman, Robin L. Dewar, Kristin L. Boswell, Richard A. Koup et al. · 2025 · Journal of Allergy and Clinical Immunology
93. Effectiveness and durability of a fourth dose of ancestral-strain mRNA vaccines against SARS-CoV-2 infection: a nationwide matched cohort study in Qatar
    Layan Sukik, Hiam S. Chemaitelly, Houssein H. Ayoub, Peter Valentine Coyle, Patrick Tang, Mohammad R. Hasan, Hadi Mohamad Yassine, Asmaa A. Al Thani, Zaina Al Kanaani, Einas Al‐Kuwari et al. · 2025 · Scientific Reports
94. B-Cell Responses to Sars-Cov-2 mRNA Vaccines
    Lela Kardava, Clarisa M. Buckner, Susan L. Moir · 2022 · Pathogens and Immunity
95. A deterministic compartmental model for the transition between variants in the spread of Covid-19 in Italy
    Mario Saviano, Annalisa Fierro, Antonella Liccardo B · 2023 · PLoS ONE
96. Single intranasal immunization with attenuated Wuhan-like SARS-CoV-2 provides highly effective cross-protection against Delta and Omicron variants of concern
    Е. Б. Файзулоев, Anastasiia V. Gracheva, E. R. Korchevaya, Yu. I. Ammour, Daria I. Smirnova, Darya M. Khokhlova, Andrey O. Drokov, Andrey A. Pankratov, Galina V. Trunova, Хохлова Варвара Андреевна et al. · 2024 · Journal of microbiology epidemiology immunobiology
97. Impact of COVID-19 Vaccination on Hospitalization and Mortality: A Comparative Analysis of Clinical Outcomes During the Early Phase of the Pandemic
    Brenda Garduño-Orbe, Paola Selene Palma-Ramírez, Eduardo López‐Ortiz, Gabriela García-Morales, Juan Manuel Sánchez-Rebolledo, Alexis Emigdio-Loeza, Anel Gómez‐García, Geovani López-Ortiz · 2025 · Infectious Disease Reports
98. Immune histories and natural infection protection during the omicron era
    Hiam S. Chemaitelly, Houssein H. Ayoub, Niklas Bobrovitz, Peter Valentine Coyle, Patrick Tang, Mohammad R. Hasan, Hadi Mohamad Yassine, Asmaa A. Al Thani, Zaina Al Kanaani, Einas Al‐Kuwari et al. · 2025 · Communications Medicine
99. Mutation and codon bias analysis of the spike protein of Omicron, the recent variant of SARS-CoV-2
    Yunbiao Lu, Weixiu Wang, Hao Liu, Yue Li, Ge Yan, Giovanni Franzo, Jianjun Dai, Wanting He · 2023 · International Journal of Biological Macromolecules
100. Study of the cellular and humoral immune responses to SARS-CoV-2 vaccination
     Faustine Montmaneix-Engels, Chloé Dimeglio, Laeticia Staes, Isabelle Da Silva, Marion Porcheron, Isabelle Jougla, Fabrice Hérin, Jacques Izopet · 2024 · Heliyon